Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.3161 per EA under NDC 00591264001. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Nov 16, 2009. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Butalbital, Acetaminophen, and Caffeine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE
Butalbital, Acetaminophen, and CaffeineStrength
300; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591264001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA040885FDA Approved
11/16/2009
TE Code
AA
On Market Since
7/29/2013
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 649 times since Mar 19, 2014, and over the history we have for it it has declined 83.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3161 per EA |
|---|---|
| All-time high | $2.6900 (Jul 15, 2015) |
| All-time low | $0.3110 (Apr 22, 2026) |
| 52-week high | $0.4517 |
| 52-week low | $0.3110 |
| Median price | $1.5100 |
| Average price | $1.3822 |
| Largest weekly change | +34.5% (Jun 19, 2024) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.3161 per EA (NDC 00591264001), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 83.9%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
Since Mar 19, 2014, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $2.6900 (Jul 15, 2015), with a median of $1.5100 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 00591264001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.